Strict Standards: Non-static method Mod_Info::nextitem() should not be called statically in /www/wwwroot/2017/feifanchem.com/source/widget/info_detail.php on line 100
FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women TUESDAY, April 16, 2019 -- The U.S. Food and Drug Administration on Tuesday announced a ban on the sale of all pelvic mesh products.-News Center-Changzhou Extraordinary Pharmatech co.,LTD-
Welcome to our website!
Deutsche Español français italiano português 日本語 한국어 العربية русский bahasa Indonesia Tiếng Việt

Your Location：Home>News Center >> Industry news >> FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women

FDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in Women

TUESDAY, April 16, 2019 -- The U.S. Food and Drug Administration on Tuesday announced a ban on the sale of all pelvic mesh products.

"In order for these mesh devices to stay on the market, we determined that we needed evidence that they worked better than surgery without the use of mesh to repair pelvic organ prolapse," Jeffrey Shuren, M.D., director of the FDA Center for Devices and Radiological Health, said in a statement. "That evidence was lacking in these premarket applications, and we couldn't assure women that these devices were safe and effective long term."

Simply put, the remaining makers of the mesh devices -- Boston Scientific and Coloplast -- failed to prove the long-term safety or benefit of their devices, the FDA said in a news release. The companies will have 10 days to submit plans to withdraw these products from the market.

The FDA has issued repeated warnings about the risks associated with using transvaginal mesh for pelvic organ prolapse repair. Women who have had the procedure should continue with routine checkups. No additional measures are needed if they are satisfied with their surgery and do not have complications or symptoms. Those who do have complications or symptoms -- such as persistent vaginal bleeding or discharge, pelvic or groin pain, or pain with sex -- should see their health care provider, the agency added. They should also inform their health care provider if they have surgical mesh, especially if they are scheduled for another surgery or medical procedure.

Hits：    【Print】
Pre：FDA Approves Expanded Monotherapy Label for Merck’s Keytruda (pembrolizumab) for First-Line Treatment of NSCLC     Next：Fennel: A Food Lovers Dream Ingredient

Recnet News

Recommended Products

　
Customer Service Hotline
Tel:+86 519 82111935
Email:info@feifanchem.com
Mobile:+86 15195055733(whats)
Address:No.4 HouYang chemical industrial park.Changzhou,Jiangsu,province,P.R.China.
CopyRight 2022 Extraordinary Pharmatech www.feifanchem.com     

  Send Email

Skype  Skype

3391543003  3391543003

 +86 15195055733

LiveChatclose